An exploratory biomarker study of immunecheckpoint inhibitors using tumor tissue and peripheral blood

Not Applicable

• Conditions: lung cancer, and melanoma

• Registration Number: JPRN-UMIN000024414
• Lead Sponsor: Wakayama Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-14
• Study Completion: 2021-01-12
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To examine the utility of tissue and blood biomarkers before and during treatment.